- Home
- LXRX vs SOR Comparison
LXRX vs SOR Comparison
Compare LXRX & SOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LXRX | SOR |
|---|---|---|
| Founded | 1995 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 465.2M | 391.5M |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | LXRX | SOR |
|---|---|---|
| Price | $1.31 | $48.69 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $3.23 | N/A |
| AVG Volume (30 Days) | ★ 4.1M | 16.2K |
| Earning Date | 03-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.24% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 6.50 |
| Revenue | ★ $70,864,000.00 | N/A |
| Revenue This Year | $56.61 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $6.41 |
| Revenue Growth | ★ 1255.21 | N/A |
| 52 Week Low | $0.28 | $36.41 |
| 52 Week High | $1.83 | $42.75 |
Technical Indicators
Market Signals| Indicator | LXRX | SOR |
|---|---|---|
| Relative Strength Index (RSI) | 49.20 | 55.32 |
| Support Level | $1.17 | $47.45 |
| Resistance Level | $1.39 | $50.00 |
| Average True Range (ATR) | 0.14 | 0.85 |
| MACD | -0.01 | -0.06 |
| Stochastic Oscillator | 33.61 | 40.39 |
Price Performance
Historical ComparisonAbout LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
About SOR Source Capital Inc.
Source Capital Inc is a diversified, closed-end management investment company. The investment objective of the company is to seek maximum total return for Common shareholders from both capital appreciation and investment income to the extent consistent with the protection of invested capital.